Trial Profile
Immunogenicity and Safety of Adjuvant and Adjuvant-Free Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 26 Apr 2021
Price :
$35
*
At a glance
- Drugs Hib-meningococcal vaccine groups A and C conjugate (Primary)
- Indications Haemophilus infections; Meningococcal group A infections; Meningococcal group C infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Beijing Zhifei Lvzhu Biopharmaceutical
- 06 Oct 2016 New trial record